Literature DB >> 32966476

Metabolism and pharmacological activities of the natural health-benefiting compound diosmin.

Yizhou Zheng1, Rui Zhang1, Weimei Shi1, Linfu Li1, Hai Liu1, Zhixi Chen1, Longhuo Wu1.   

Abstract

Diosmin is a famous natural flavonoid for treating chronic venous insufficiency and varicose veins. Recently, extensive study has indicated that diosmin possesses diverse pharmacological activities, including anti-inflammation, anti-oxidation, anti-diabetes, anti-cancer, anti-microorganism, liver protection, neuro-protection, cardiovascular protection, renoprotection, and retinal protection activities. Due to its low water solubility, diosmin is dramatically limited in clinical application. Expectedly, many potential strategies have been developed for improving its pharmacokinetic values and bioavailability. This health-benefiting compound has been explored as the major component of Daflon and micronized purified flavonoid fraction (MPFF), which have been used in clinics to improve micro-circulation. However, no specific drug targets for diosmin are reported, although some potential factors have been involved in screening, such as P-glycoprotein (P-gp), IKKβ, acetylcholinesterase (AChE), and aldose reductase (AR). More investigations on the underlying mechanisms of diosmin in mediating cellular processes with high specificity is still needed.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32966476     DOI: 10.1039/d0fo01598a

Source DB:  PubMed          Journal:  Food Funct        ISSN: 2042-6496            Impact factor:   5.396


  11 in total

Review 1.  Pharmacology of Diosmin, a Citrus Flavone Glycoside: An Updated Review.

Authors:  Samar H Gerges; Sara A Wahdan; Doaa A Elsherbiny; Ebtehal El-Demerdash
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2021-10-23       Impact factor: 2.441

Review 2.  The Signaling Pathways and Targets of Natural Compounds from Traditional Chinese Medicine in Treating Ischemic Stroke.

Authors:  Xing-Hua Li; Feng-Ting Yin; Xiao-Hang Zhou; Ai-Hua Zhang; Hui Sun; Guang-Li Yan; Xi-Jun Wang
Journal:  Molecules       Date:  2022-05-12       Impact factor: 4.927

3.  Citrus limon Peel Powder Reduces Intestinal Barrier Defects and Inflammation in a Colitic Murine Experimental Model.

Authors:  Nguyen Thi Thanh Tinh; Gertrude Cynthia Sitolo; Yoshinari Yamamoto; Takuya Suzuki
Journal:  Foods       Date:  2021-01-25

Review 4.  Buchu (Agathosma betulina and A. crenulata): Rightfully Forgotten or Underutilized?

Authors:  Thomas Brendler; Mona Abdel-Tawab
Journal:  Front Pharmacol       Date:  2022-02-07       Impact factor: 5.810

5.  Flavonoids: Antiplatelet Effect as Inhibitors of COX-1.

Authors:  Cristina Zaragozá; Miguel Ángel Álvarez-Mon; Francisco Zaragozá; Lucinda Villaescusa
Journal:  Molecules       Date:  2022-02-08       Impact factor: 4.411

Review 6.  The Role of Flavonoids in the Osteogenic Differentiation of Mesenchymal Stem Cells.

Authors:  Jinli Zhang; Zhihe Liu; Yang Luo; Xiaojian Li; Guowei Huang; Huan Chen; Aiguo Li; Shengnan Qin
Journal:  Front Pharmacol       Date:  2022-04-06       Impact factor: 5.988

Review 7.  The Benefits of Flavonoids in Diabetic Retinopathy.

Authors:  Ana L Matos; Diogo F Bruno; António F Ambrósio; Paulo F Santos
Journal:  Nutrients       Date:  2020-10-16       Impact factor: 5.717

8.  Disposable Pencil Graphite Electrode for Diosmin Voltammetric Analysis.

Authors:  Iulia Gabriela David; Alexandra-Gabriela Oancea; Mihaela Buleandră; Dana Elena Popa; Emilia Elena Iorgulescu; Adela Magdalena Ciobanu
Journal:  Micromachines (Basel)       Date:  2021-03-25       Impact factor: 2.891

9.  Assessment of Platelet Reactivity and Inflammatory Markers in Coronary Artery Bypass Graft Patients Treated with Acetylsalicylic Acid with Flavonoid Supplementation.

Authors:  Aldona Siennicka; Magdalena Kłysz; Monika Adamska; Kornel Chełstowski; Andrzej Biskupski; Maria Jastrzębska
Journal:  Molecules       Date:  2021-12-10       Impact factor: 4.411

10.  Activating AhR alleviates cognitive deficits of Alzheimer's disease model mice by upregulating endogenous Aβ catabolic enzyme Neprilysin.

Authors:  Cheng Qian; Chunjie Yang; Mengting Lu; Jiaxin Bao; Haiyan Shen; Bingquan Deng; Shensen Li; Wenwen Li; Mu Zhang; Changchun Cao
Journal:  Theranostics       Date:  2021-08-11       Impact factor: 11.556

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.